{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T07:02:49Z","timestamp":1789455769113,"version":"build-2803163510"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,8]],"date-time":"2024-08-08T00:00:00Z","timestamp":1723075200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Dependence Reports"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.dadr.2024.100270","type":"journal-article","created":{"date-parts":[[2024,8,13]],"date-time":"2024-08-13T16:50:56Z","timestamp":1723567856000},"page":"100270","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Benzodiazepine use for anxiety disorders is associated with increased long-term risk of mood and substance use disorders: A large-scale retrospective cohort study"],"prefix":"10.1016","volume":"12","author":[{"given":"Ching-Fang","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akhil S.","family":"Pola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuan-Pin","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Binx Y.","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita S.","family":"Kablinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert L.","family":"Trestman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.dadr.2024.100270_bib1","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2018.7399","article-title":"Patterns in outpatient benzodiazepine prescribing in the United States","volume":"2","author":"Agarwal","year":"2019","journal-title":"JAMA Netw. Open"},{"issue":"4","key":"10.1016\/j.dadr.2024.100270_bib2","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1177\/1039856215590053","article-title":"Anxiety and substance use disorders: a worrying combination","volume":"23","author":"Arunogiri","year":"2015","journal-title":"Austral Psychiatry"},{"issue":"1-2","key":"10.1016\/j.dadr.2024.100270_bib3","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0740-5472(91)90023-4","article-title":"Protracted withdrawal syndromes from benzodiazepines","volume":"8","author":"Ashton","year":"1991","journal-title":"J. Subst. Abus. Treat."},{"issue":"4","key":"10.1016\/j.dadr.2024.100270_bib4","doi-asserted-by":"crossref","first-page":"686","DOI":"10.2105\/AJPH.2016.303061","article-title":"Increasing benzodiazepine prescriptions and overdose mortality in the United States, 1996-2013","volume":"106","author":"Bachhuber","year":"2016","journal-title":"Am. J. Public Health"},{"issue":"2","key":"10.1016\/j.dadr.2024.100270_bib5","doi-asserted-by":"crossref","first-page":"153","DOI":"10.31887\/DCNS.2008.10.2\/lclark","article-title":"Cognitive neuroscience and brain imaging in bipolar disorder","volume":"10","author":"Clark","year":"2008","journal-title":"Dialog-. Clin. Neurosci."},{"key":"10.1016\/j.dadr.2024.100270_bib6","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.drugalcdep.2018.02.011","article-title":"Examining racial\/ethnic differences in patterns of benzodiazepine prescription and misuse","volume":"187","author":"Cook","year":"2018","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.dadr.2024.100270_bib7","doi-asserted-by":"crossref","unstructured":"Cornwell, A.C., Tisdale, A.A., Venkat, S., Maraszek, K.E., Alahmari, A.A., George, A., Attwood, K., George, M., Rempinski, D., Franco-Barraza, J., Parker, M.D., Gomez, E.C., Fountzilas, C., Cukierman, E., Steele, N.G., & Feigin, M.E. (2023). Lorazepam stimulates IL-6 production and is associated with poor survival outcomes in pancreatic cancer. medRxiv, 2023.2003.2001.23286581. https:\/\/doi.org\/10.1101\/2023.03.01.23286581","DOI":"10.1101\/2023.03.01.23286581"},{"issue":"5","key":"10.1016\/j.dadr.2024.100270_bib8","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1159\/000506868","article-title":"Acute and persistent withdrawal syndromes following discontinuation of psychotropic medications","volume":"89","author":"Cosci","year":"2020","journal-title":"Psychother. Psychosom."},{"issue":"6","key":"10.1016\/j.dadr.2024.100270_bib9","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1080\/13543776.2020.1746764","article-title":"GABA(A) receptor subtype modulators in medicinal chemistry: an updated patent review (2014-present)","volume":"30","author":"Crocetti","year":"2020","journal-title":"Expert Opin. Ther. Pat."},{"issue":"1","key":"10.1016\/j.dadr.2024.100270_bib10","first-page":"85","article-title":"Cohort study of the impact of high-dose opioid analgesics on overdose mortality","volume":"17","author":"Dasgupta","year":"2016","journal-title":"Pain. Med."},{"issue":"4","key":"10.1016\/j.dadr.2024.100270_bib11","doi-asserted-by":"crossref","first-page":"594","DOI":"10.3390\/neurolint13040059","article-title":"Benzodiazepines: uses, Dangers, and Clinical Considerations","volume":"13","author":"Edinoff","year":"2021","journal-title":"Neurol. Int."},{"issue":"8","key":"10.1016\/j.dadr.2024.100270_bib12","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1001\/archpsyc.61.8.807","article-title":"Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions","volume":"61","author":"Grant","year":"2004","journal-title":"Arch. Gen. Psychiatry"},{"issue":"1-3","key":"10.1016\/j.dadr.2024.100270_bib13","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.jad.2007.04.014","article-title":"Neuropsychological performance predicts clinical recovery in bipolar patients","volume":"105","author":"Gruber","year":"2008","journal-title":"J. Affect Disord."},{"issue":"3","key":"10.1016\/j.dadr.2024.100270_bib14","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1111\/j.1751-7893.2008.00076.x","article-title":"Motives for substance use among young people seeking mental health treatment","volume":"2","author":"Hides","year":"2008","journal-title":"Early Inter. Psychiatry"},{"issue":"2","key":"10.1016\/j.dadr.2024.100270_bib15","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1365-2125.2012.04418.x","article-title":"Benzodiazepine harm: how can it be reduced?","volume":"77","author":"Lader","year":"2014","journal-title":"Br. J. Clin. Pharm."},{"issue":"1","key":"10.1016\/j.dadr.2024.100270_bib16","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1186\/s12888-016-1075-3","article-title":"Insomnia and the risk of depression: a meta-analysis of prospective cohort studies","volume":"16","author":"Li","year":"2016","journal-title":"BMC Psychiatry"},{"issue":"1","key":"10.1016\/j.dadr.2024.100270_bib17","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.pbb.2008.03.006","article-title":"GABA(A) receptors and alcohol","volume":"90","author":"Lobo","year":"2008","journal-title":"Pharm. Biochem Behav."},{"issue":"5","key":"10.1016\/j.dadr.2024.100270_bib18","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1176\/ajp.144.5.664","article-title":"Emergence of depressive symptoms in patients receiving alprazolam for panic disorder","volume":"144","author":"Lydiard","year":"1987","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.dadr.2024.100270_bib19","unstructured":"Margareten, J.N. (2011). Should Benzodiazepines Be Prescribed to Treat Insomnia and Anxiety Related Disorders?. The Science Journal of the Lander College of Arts and Sciences, 4(2). Retrieved from https:\/\/touroscholar.touro.edu\/sjlcas\/vol4\/iss2\/2"},{"issue":"10","key":"10.1016\/j.dadr.2024.100270_bib20","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.31012","article-title":"Trends in the Use of Benzodiazepines, Z-Hypnotics, and Serotonergic Drugs Among US Women and Men Before and During the COVID-19 Pandemic","volume":"4","author":"Milani","year":"2021","journal-title":"JAMA Netw. Open"},{"issue":"2","key":"10.1016\/j.dadr.2024.100270_bib21","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1001\/jamainternmed.2016.7507","article-title":"Adult utilization of psychiatric drugs and differences by sex, age, and race","volume":"177","author":"Moore","year":"2017","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.dadr.2024.100270_bib22","first-page":"1","article-title":"The use of benzodiazepines in bipolar disorders","volume":"2","author":"Otheman","year":"2018","journal-title":"Addict. Clin. Res"},{"key":"10.1016\/j.dadr.2024.100270_bib23","doi-asserted-by":"crossref","first-page":"h2698","DOI":"10.1136\/bmj.h2698","article-title":"Benzodiazepine prescribing patterns and deaths from drug overdose among US veterans receiving opioid analgesics: case-cohort study","volume":"350","author":"Park","year":"2015","journal-title":"BMJ: Br. Med. J."},{"issue":"1","key":"10.1016\/j.dadr.2024.100270_bib24","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1177\/2049463712438493","article-title":"Basic opioid pharmacology: an update","volume":"6","author":"Pathan","year":"2012","journal-title":"Br. J. Pain."},{"key":"10.1016\/j.dadr.2024.100270_bib25","doi-asserted-by":"crossref","first-page":"j2941","DOI":"10.1136\/bmj.j2941","article-title":"Benzodiazepines and risk of all cause mortality in adults: cohort study","volume":"358","author":"Patorno","year":"2017","journal-title":"BMJ (Clin. Res. Ed. )"},{"issue":"2","key":"10.1016\/j.dadr.2024.100270_bib26","doi-asserted-by":"crossref","first-page":"194","DOI":"10.4088\/JCP.09m05019yel","article-title":"Benzodiazepine use and risk of recurrence in bipolar disorder: a STEP-BD report","volume":"71","author":"Perlis","year":"2010","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.dadr.2024.100270_bib27","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1038\/463743a","article-title":"Neuroscience: lack of inhibition leads to abuse","volume":"463","author":"Riegel","year":"2010","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.dadr.2024.100270_bib28","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s12974-021-02100-7","article-title":"On inflammatory hypothesis of depression: what is the role of IL-6 in the middle of the chaos?","volume":"18","author":"Roohi","year":"2021","journal-title":"J. Neuroinflamm."},{"issue":"3","key":"10.1016\/j.dadr.2024.100270_bib29","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1002\/da.23113","article-title":"Co-morbidity between mood and anxiety disorders: a systematic review and meta-analysis","volume":"38","author":"Saha","year":"2021","journal-title":"Depress Anxiety"},{"key":"10.1016\/j.dadr.2024.100270_bib30","doi-asserted-by":"crossref","first-page":"j760","DOI":"10.1136\/bmj.j760","article-title":"Association between concurrent use of prescription opioids and benzodiazepines and overdose: retrospective analysis","volume":"356","author":"Sun","year":"2017","journal-title":"Bmj"},{"key":"10.1016\/j.dadr.2024.100270_bib31","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/nature08758","article-title":"Neural bases for addictive properties of benzodiazepines","volume":"463","author":"Tan","year":"2010","journal-title":"Nature"},{"issue":"S6","key":"10.1016\/j.dadr.2024.100270_bib32","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.5694\/mja12.10628","article-title":"Depression and anxiety","volume":"199","author":"Tiller","year":"2013","journal-title":"Med J. Aust."},{"issue":"23","key":"10.1016\/j.dadr.2024.100270_bib33","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph182312438","article-title":"Geriatric Depression and Inappropriate Medication: benefits of Interprofessional Team Cooperation in Nursing Homes","volume":"18","author":"Vankova","year":"2021","journal-title":"Int J. Environ. Res Public Health"},{"key":"10.1016\/j.dadr.2024.100270_bib34","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.drugalcdep.2019.02.033","article-title":"The epidemiology of benzodiazepine misuse: a systematic review","volume":"200","author":"Votaw","year":"2019","journal-title":"Drug Alcohol Depend."},{"issue":"9","key":"10.1016\/j.dadr.2024.100270_bib35","doi-asserted-by":"crossref","first-page":"538","DOI":"10.4140\/TCP.n.2013.538","article-title":"The history of benzodiazepines","volume":"28","author":"Wick","year":"2013","journal-title":"Consult Pharm."},{"issue":"4044","key":"10.1016\/j.dadr.2024.100270_bib36","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1126\/science.177.4044.180","article-title":"Benzodiazepines: anxiety-reducing activity by reduction of serotonin turnover in the brain","volume":"177","author":"Wise","year":"1972","journal-title":"Science"},{"key":"10.1016\/j.dadr.2024.100270_bib37","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.jad.2019.06.052","article-title":"Prevalence and clinical profiles of comorbid anxiety in first episode and drug na\u00efve patients with major depressive disorder","volume":"257","author":"Yang","year":"2019","journal-title":"J. Affect Disord."}],"container-title":["Drug and Alcohol Dependence Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772724624000544?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772724624000544?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T00:10:24Z","timestamp":1726704624000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772724624000544"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":37,"alternative-id":["S2772724624000544"],"URL":"https:\/\/doi.org\/10.1016\/j.dadr.2024.100270","relation":{},"ISSN":["2772-7246"],"issn-type":[{"value":"2772-7246","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Benzodiazepine use for anxiety disorders is associated with increased long-term risk of mood and substance use disorders: A large-scale retrospective cohort study","name":"articletitle","label":"Article Title"},{"value":"Drug and Alcohol Dependence Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dadr.2024.100270","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100270"}}